Boston Scientific to Acquire Penumbra for $14.5 Billion
Boston Scientific Corporation (BSX) entered a merger agreement on January 15, 2026, to acquire Penumbra, Inc. (PEN) in a deal valued at $14.5 billion. Deal Structure: The deal…
Written byAsif SuriaSource: InsideArbitrage
Boston Scientific Corporation (BSX) entered a merger agreement on January 15, 2026, to acquire Penumbra, Inc. (PEN) in a deal valued at $14.5 billion. Deal Structure: The deal values each Penumbra share at $374, with Penumbra stockholders having the right to elect to receive $374 in cash or 3.8721 shares of Boston Scientific common stock.